MURA: muraloncology.com Quarterly Revenue Growth

Symbol and logo of brand muraloncology.com (MURA)

Quarterly revenue growth rates confirm the effectiveness of Caroline Lowe's management in transitioning Mural Oncology plc (MURA) toward autonomy. The business relies on patent protection for interleukins, which ensure high margins. However, success depends on the safety of genetic developments and the availability of investment. The 0.00 mark shows the current state of the indicator, allowing for a comparison of the current trend with the company's historical development retrospective.

MURA muraloncology.com Revenue Growth QoQ (02/21/2024 - 12/20/2025)

Analytical breakdowns and data insights for company Mural Oncology plc (MURA)

- current quotes and average value forecast:
- cash and cash flow data:
Fundamental valuation:Mural Bio (MURA)
Mass-produced product of Mural Bio

This indicator measures the growth rate of operating revenues between consecutive quarters, allowing investors to identify a slowdown in commercial activity prior to the publication of official financial statements. While analyzing the quarterly revenue growth rate helps filter out speculative noise, for Mural Oncology (MURA), which has no commercial products, the metric highlights the absence of current cash flows and the total dependence of its capitalization on clinical trial results.

Competitor analysis

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase DCTH|YMAB: Quarterly Sales Growth|Quarterly Revenue Growth Rate Aura Corp|CADL: Quarterly Revenue Growth|ARAY - Quarterly Sales Growth Rate|SLS (SELLAS Life Sciences Group, Inc.) - Quarterly Revenue Growth|ACTU: Quarterly Revenue Increase|Revenue Growth QoQ citiusonc.com (CTOR)|Quarterly Sales Growth Rate TuHURA Biosciences|Revenue Growth QoQ Protara Therapeutics TARA|Fate Therapeutics (FATE) - Quarterly Revenue Growth Rate|WHWK - Revenue Growth QoQ|Quarterly Revenue Growth Rate TScan Therapeutics Inc|championsoncology.com (CSBR) - Revenue Growth QoQ|Sales Growth QoQ XBIT|Quarterly Sales Growth CVM|Sales Growth QoQ OSTX (OS Therapies Incorporated)|Quarterly Revenue Growth RADX|ARTV: Revenue Dynamics QoQ|Quarterly Revenue Growth ANL (Adlai Nortye Ltd)|VERU - Quarterly Sales Growth|tempesttx.com - Quarterly Revenue Growth|Quarterly Revenue Increase XLO (xiliotx.com)|RENB: Quarterly Revenue Growth|Kairos Pharma Inc (KAPA) - Quarterly Revenue Growth|Quarterly Sales Growth OKUR|CytoMed Therapeutics (GDTC) - Quarterly Sales Growth Rate|Quarterly Sales Growth CRIS (Curis Inc.)|Quarterly Revenue Growth Apollomics Inc. (APLM)|Revenue Growth QoQ Tharimmune Corp THAR|Advanced Biomed Corp - Revenue Growth QoQ|GNPX: Quarterly Sales Growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly Sales Growth|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)